Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058398) titled 'Evaluation of short-term changes in glycemic management indicators before and after initiating once-weekly basal insulin' on July 8.
Study Type:
Observational
Primary Sponsor:
Institute - Asahikawa Medical University
Condition:
Condition - Type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the short-term efficacy and safety of initiating insulin icodec.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Patients with type 2 diabetes with HbA1c levels of 7% or higher who are scheduled to initiate insulin icodec
Key exclusion criteria - 1) Type 1 diabetes
2) Gestational diabetes
3) Diabetic ketoacidosis
4) Inappropriate as study subjects by the principal investigator
Target Size - 20
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 06 Month 23 Day
Date of IRB - 2025 Year 06 Month 23 Day
Anticipated trial start date - 2025 Year 06 Month 23 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066763
Disclaimer: Curated by HT Syndication.
